Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessStocks

Buy Max Healthcare Institute; target of Rs 500: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 500 in its research report dated November 03, 2022.

November 03, 2022 / 08:24 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher's research report on Max Healthcare Institute

Max Healthcare (MAXHEALT) reported EBITDA of Rs 4bn (up 9% QoQ) vs our estimate of Rs3.9bn. Overall occupancy stood at 78% vs 74% in Q1 on seasonality, while ARPOB remained steady QoQ at Rs.66K due to medical mix obligation. The company became net cash positive by Rs. 420mn vs Rs. 2.1bn of net debt in Q1. Operational efficiency has also been commendable, especially in competitive markets like NCR. MAXHEALT has shown phenomenal growth in past two years and we expect this momentum to continue given 1) strong expansion plans, 2) improving payor mix and 3) scale up in labs. Our FY23E and FY24E EBITDA broadly remains unchanged.


Outlook

We expect 17% EBITDA CAGR over FY22-25E. We ascribe 24x EV/EBITDA (22x earlier) to hospital segment and 25x EV/EBITDA to diagnostic segment. Maintain ‘Buy’ rating with increased TP of Rs 500/share (earlier at Rs 427/share), as we roll forward to Sept 2024.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Max Healthcare Institute - 03-11-2022 - prabhu

Broker Research
first published: Nov 3, 2022 08:24 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347